{"text": ["AbbVie", "(ABBV)", "Gets", "FDA", "Nod", "for", "Label", "Expansion", "of", "HCV", "Drug"], "created_at": "2019-09-27 21:38:09"}
{"text": ["FTC", "requests", "AbbVie,", "Allergan", "for", "more", "information", "on", "$63", "billion", "deal"], "created_at": "2019-09-27 20:57:08"}
{"text": ["FTC", "requests", "AbbVie,", "Allergan", "for", "more", "information", "on", "$63", "bln", "deal"], "created_at": "2019-09-27 20:50:52"}
{"text": ["Allergan", "and", "AbbVie", "Receive", "Second", "Request", "from", "Federal", "Trade", "Commission", "on", "Pending", "Transaction"], "created_at": "2019-09-27 20:16:00"}
{"text": ["AbbVie", "and", "Allergan", "Receive", "Second", "Request", "from", "Federal", "Trade", "Commission", "on", "Pending", "Transaction"], "created_at": "2019-09-27 20:15:00"}
{"text": ["This", "is", "Why", "AbbVie", "(ABBV)", "is", "a", "Great", "Dividend", "Stock"], "created_at": "2019-09-27 13:15:01"}
{"text": ["AbbVie", "Receives", "FDA", "Approval", "of", "MAVYRET\u00ae", "(glecaprevir/pibrentasvir)", "to", "Shorten", "Treatment", "Duration", "to", "Eight", "Weeks", "for", "Treatment-Na\u00efve", "Patients", "with", "Chronic", "Hepatitis", "C", "and", "Compensated", "Cirrhosis", "Across", "All", "Genotypes"], "created_at": "2019-09-27 00:00:00"}
